Both BA9 and BT942 reduced the proportion of hCD25+Foxp3+ cells and Foxp3+(Treg) cells in the tumor at early or late phase treatment experiment (Fig. 5c,d,h,i). The gene discussed is FOXP3; the disease is neoplasm.